tiprankstipranks
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market

Lyell Immunopharma (LYEL) Balance Sheet

57 Followers

Lyell Immunopharma Balance Sheet

Lyell Immunopharma's total assets for Q4 2023 were $750.03M, a decrease of -5.66% from the previous quarter. LYEL total liabilities were $95.08M for the fiscal quarter, a -2.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 750.03M$ 937.56M$ 1.13B$ 908.28M$ 555.63M
Total Liabilities
$ 95.08M$ 104.31M$ 197.62M$ 189.84M$ 147.58M
Total Equity Gross Minority
$ 654.95M$ 833.25M$ 929.79M$ 718.44M$ 408.06M
Total Capitalization
$ 711.85M$ 896.42M$ 929.79M$ 718.44M$ 408.06M
Preferred Stock Equity
---$ 1.01B$ 519.16M
Capital Lease Obligations
---$ 54.57M$ 27.47M
Currency in USD

Lyell Immunopharma Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis